Supplement encyclopedia

Berberine

Berberine is a plant compound in the alkaloid family. Barberry is one of the plants that contain it. Supplement studies used tablets and capsules containing isolated berberine. The berries and other parts of the plant have a different composition.

Double-check the conclusions and review the sources before choosing a supplement.

Main conclusion

Potential benefits

  • In adults with irritable bowel syndrome and diarrhea, diarrhea and abdominal pain occurred less often over eight weeks of taking berberine hydrochloride than with vitamin C. Four weeks after use ended, no clear difference in diarrhea frequency was found anymore.
  • In young adults, a one-hour run at 35 °C felt easier after a week of taking berberine than after placebo.
  • In adults with newly detected high blood sugar, berberine reduced fasting blood sugar by an average of 0.50 mmol/L more than placebo over 16 weeks.
  • In adults without diabetes who had obesity and fatty liver disease, berberine reduced LDL cholesterol by about 7.7 mg/dL more than placebo over six months.
  • In the same group over six months, no additional reduction in weight or fat around the internal organs was found with berberine compared with placebo.

[1] [2] [3] [4]

What researchers studied

  • In the study of intestinal symptoms, participants with diarrhea also rated their quality of life: over eight weeks, the score increased more with berberine than with vitamin C.
  • Berberine may interact with medicines, for example by increasing exposure to midazolam and cyclosporine concentrations. Before combining it with medicines, check their compatibility with a doctor or pharmacist.
  • Berberine should be avoided during pregnancy and breastfeeding; ANSES also recommends avoiding supplements containing it for children and adolescents and for people with diabetes, liver disease, or heart disease.

[1] [2] [3] [4]

Forms studied

  • For intestinal symptoms, berberine hydrochloride tablets were studied at 200 mg twice daily for eight weeks.
  • The trial in adults with obesity used hydrochloride at 500 mg twice daily for six months; the trial in people with high blood sugar used berberine tablets at 500 mg twice daily for 16 weeks.
  • The running experiment used berberine capsules at 750 mg twice daily for seven days. The article did not specify the salt form in the capsules.

[1] [2] [3] [4]

Food sources

  • Fresh and dried common barberry berries are used in food; dried berries are added to rice dishes, for example.
  • The berries are also used to make juice, jam, marmalade, and sauces. The amount of berberine depends on the raw material and processing, so a serving of these foods cannot be equated with a dose of isolated berberine in a tablet.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Change in body weightOver six months, body weight fell by an average of 1.8 kg with berberine and 1.9 kg with placebo. The trial found no additional weight loss with berberine. The adjusted difference was +0.05 kg, with a 95% confidence interval from −0.74 to +0.84 kg.
2/4 LowConfidence is low because this was an additional outcome in one trial in a specific population. The range of the estimate allows for a small difference in either direction. This result does not mean that body weight stayed the same.
1randomized trialBerberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗The trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.
  1. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
Fat around the internal organsThe area of fat around the internal organs, measured by CT, fell by an average of 0.6% with berberine and 2.0% with placebo. The trial found no advantage for berberine. The adjusted difference in change was +1.38 percentage points, with a 97.5% confidence interval from −2.43 to +5.18.
3/4 ModerateConfidence is moderate because this was a primary outcome in a randomized trial with 337 participants. The analysis accounted for missing measurements statistically. A small difference between the groups is still possible.
1randomized trialBerberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗The trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.
  1. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
Fasting blood sugarOver 16 weeks, average fasting blood sugar went from 6.49 to 6.20 mmol/L with berberine and from 6.43 to 6.67 mmol/L in the control group. The adjusted reduction relative to control was 0.50 mmol/L, with a 95% confidence interval from 0.15 to 0.85 mmol/L.
2/4 LowConfidence is low because the evidence comes from one trial. The analysis included only participants with at least one follow-up measurement and filled in missing values with the last known value. The finding applies to people with elevated blood sugar. People with normal blood sugar are outside its scope.
1randomized trialEffectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗Adults aged 18–70 with newly identified elevated blood sugar. A total of 150 people were assigned to the two groups relevant to this comparison. The analysis included 49 in the berberine group and 99 in the control group.
  1. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Safe upper intake limit
Reference pointWhat it means
2019 ANSES opinionANSES could not establish a reliable safe intake limit. The agency’s provisional toxicological reference value does not serve as a recommended supplement dose.

ANSES Opinion on the safety of use of berberine-containing plants in the composition of food supplements — Request 2018-SA-0095 ↗

Forms

Berberine hydrochloride — This is a salt form of berberine. The IBS trial used tablets at 200 mg twice daily for eight weeks. The obesity trial used tablets at a dose of 500 mg twice daily after breakfast and dinner for six months. The shared name of the substance does not make the two regimens interchangeable. Tablets and capsules in other trials — The trial in people with elevated blood sugar used berberine tablets at 500 mg twice daily for 16 weeks. The running study used capsules at 750 mg twice daily for seven days. The articles did not specify the exact salt form. These trials did not compare the forms in a way that could establish which works best across all uses.

Guidance for each goal

Change in body weight2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low because this was an additional outcome in one trial in a specific population. The range of the estimate allows for a small difference in either direction. This result does not mean that body weight stayed the same.

Over six months, body weight fell by an average of 1.8 kg with berberine and 1.9 kg with placebo. The trial found no additional weight loss with berberine. The adjusted difference was +0.05 kg, with a 95% confidence interval from −0.74 to +0.84 kg.

Study findings. Over six months, body weight fell by an average of 1.8 kg with berberine and 1.9 kg with placebo. The trial found no additional weight loss with berberine. The adjusted difference was +0.05 kg, with a 95% confidence interval from −0.74 to +0.84 kg.

Studied regimen500 mg twice daily after breakfast and dinner, for a total of 1 g/dayBerberine hydrochloride, 100 mg tablets
Duration and populationSix monthsThe trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.

Comparator — Matching placebo tablets. Both groups received diet and physical activity advice.

Fat around the internal organs3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateConfidence is moderate because this was a primary outcome in a randomized trial with 337 participants. The analysis accounted for missing measurements statistically. A small difference between the groups is still possible.

The area of fat around the internal organs, measured by CT, fell by an average of 0.6% with berberine and 2.0% with placebo. The trial found no advantage for berberine. The adjusted difference in change was +1.38 percentage points, with a 97.5% confidence interval from −2.43 to +5.18.

Study findings. The area of fat around the internal organs, measured by CT, fell by an average of 0.6% with berberine and 2.0% with placebo. The trial found no advantage for berberine. The adjusted difference in change was +1.38 percentage points, with a 97.5% confidence interval from −2.43 to +5.18.

Studied regimen500 mg twice daily after breakfast and dinner, for a total of 1 g/dayBerberine hydrochloride, 100 mg tablets
Duration and populationSix monthsThe trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.

Comparator — Matching placebo tablets. Both groups received diet and physical activity advice.

Fasting blood sugar2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low because the evidence comes from one trial. The analysis included only participants with at least one follow-up measurement and filled in missing values with the last known value. The finding applies to people with elevated blood sugar. People with normal blood sugar are outside its scope.

Over 16 weeks, average fasting blood sugar went from 6.49 to 6.20 mmol/L with berberine and from 6.43 to 6.67 mmol/L in the control group. The adjusted reduction relative to control was 0.50 mmol/L, with a 95% confidence interval from 0.15 to 0.85 mmol/L.

Study findings. Over 16 weeks, average fasting blood sugar went from 6.49 to 6.20 mmol/L with berberine and from 6.43 to 6.67 mmol/L in the control group. The adjusted reduction relative to control was 0.50 mmol/L, with a 95% confidence interval from 0.15 to 0.85 mmol/L.

Studied regimen500 mg twice daily, for a total of 1 g/dayBerberine tablets. The article did not specify the chemical salt form.
Duration and population16 weeksAdults aged 18–70 with newly identified elevated blood sugar. A total of 150 people were assigned to the two groups relevant to this comparison. The analysis included 49 in the berberine group and 99 in the control group.

Comparator — Starch placebo tablets. Both groups also received placebo capsules in place of bifidobacteria.

LDL cholesterol2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low because LDL cholesterol was an additional outcome in one trial. Researchers assessed many outcomes without adjusting for multiple comparisons. The finding concerns a blood test and does not establish that any cardiac events were prevented.

Over six months, LDL cholesterol, often called “bad” cholesterol, fell by 7.72 mg/dL more with berberine than with placebo. The 95% confidence interval for the additional reduction was 1.93 to 13.13 mg/dL. This comparison did not assess how often heart attacks occurred.

Study findings. Over six months, LDL cholesterol, often called “bad” cholesterol, fell by 7.72 mg/dL more with berberine than with placebo. The 95% confidence interval for the additional reduction was 1.93 to 13.13 mg/dL. This comparison did not assess how often heart attacks occurred.

Studied regimen500 mg twice daily after breakfast and dinner, for a total of 1 g/dayBerberine hydrochloride, 100 mg tablets
Duration and populationSix monthsThe trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.

Comparator — Matching placebo tablets. Both groups received diet and physical activity advice.

Diarrhea frequency in IBS1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowConfidence is very low because the evidence comes from one small trial and 32 of the 164 participants were missing from the final results. Participants recorded symptom frequency themselves, and complete results are unavailable for those who dropped out.

Over eight weeks, average diarrhea frequency recorded in diaries fell by about 70% with berberine and 15% in the control group. These relative changes within each group were calculated from the table in the article. The advantage for berberine at week eight was statistically significant. Four weeks after treatment stopped, there was no longer a difference between the groups.

Study findings. Over eight weeks, average diarrhea frequency recorded in diaries fell by about 70% with berberine and 15% in the control group. These relative changes within each group were calculated from the table in the article. The advantage for berberine at week eight was statistically significant. Four weeks after treatment stopped, there was no longer a difference between the groups.

Studied regimen200 mg twice daily, for a total of 400 mg/dayBerberine hydrochloride tablets
Duration and populationEight weeks of treatment followed by four weeks of follow-upAdults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks.

Comparator — Identical-looking vitamin C tablets at 200 mg twice daily, for a total of 400 mg/day. The article refers to this control as placebo.

Abdominal pain frequency in IBS1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowConfidence is very low because the findings come from one trial with substantial dropout. Researchers assessed several symptoms repeatedly. This finding concerns pain frequency in people with IBS with diarrhea.

Over eight weeks, abdominal pain frequency recorded in diaries fell by 64.6% with berberine and 29.4% in the control group. These percentages measure the decline from baseline in each group and do not indicate how many people benefited. At week eight, the difference between the groups was statistically significant.

Study findings. Over eight weeks, abdominal pain frequency recorded in diaries fell by 64.6% with berberine and 29.4% in the control group. These percentages measure the decline from baseline in each group and do not indicate how many people benefited. At week eight, the difference between the groups was statistically significant.

Studied regimen200 mg twice daily, for a total of 400 mg/dayBerberine hydrochloride tablets
Duration and populationEight weeks of treatmentAdults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks.

Comparator — Identical-looking vitamin C tablets at 200 mg twice daily, for a total of 400 mg/day. The article refers to this control as placebo.

Quality of life in IBS1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowConfidence is very low because this was an additional questionnaire in one trial with participant dropout. The questionnaire assessed quality of life in people with IBS. It did not assess mood in healthy people.

Over eight weeks, the average score on an IBS quality-of-life questionnaire rose from 122.20 to 158.47 points with berberine and from 126.63 to 131.57 points in the control group. Higher scores indicate better quality of life. The changes were +36.27 and +4.94 points, respectively. The difference between the groups at the end of treatment was statistically significant.

Study findings. Over eight weeks, the average score on an IBS quality-of-life questionnaire rose from 122.20 to 158.47 points with berberine and from 126.63 to 131.57 points in the control group. Higher scores indicate better quality of life. The changes were +36.27 and +4.94 points, respectively. The difference between the groups at the end of treatment was statistically significant.

Studied regimen200 mg twice daily, for a total of 400 mg/dayBerberine hydrochloride tablets
Duration and populationEight weeks of treatmentAdults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks.

Comparator — Identical-looking vitamin C tablets at 200 mg twice daily, for a total of 400 mg/day. The article refers to this control as placebo.

Perceived exertion while running in the heat2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low because the study included only eight participants and treatment was brief. The study measured several responses to the same workload. It did not assess improvements in speed or endurance.

In eight young adults doing the same one-hour run in the heat, average perceived exertion was 1.7 points lower with berberine, at 11.4 points versus 13.1 points with placebo. Participants ran at 35 °C at an intensity of about 60% of their individual maximal oxygen uptake. The trial did not assess athletic performance or protection against overheating.

Study findings. In eight young adults doing the same one-hour run in the heat, average perceived exertion was 1.7 points lower with berberine, at 11.4 points versus 13.1 points with placebo. Participants ran at 35 °C at an intensity of about 60% of their individual maximal oxygen uptake. The trial did not assess athletic performance or protection against overheating.

Studied regimen750 mg with food in the morning and evening, for a total of 1.5 g/day. The last dose was taken about an hour before the test.Capsules containing berberine of more than 99% purity. The salt form was not specified.
Duration and populationSeven days on each treatment, with 14 days off between periodsEight young adults, six men and two women. Each completed both periods in random order.

Comparator — Maltodextrin capsules, for a total of 1.5 g/day

Safety and limitations

Abdominal pain or discomfort, nausea, vomiting, constipation, and diarrhea can occur while taking berberine. Avoid berberine during pregnancy and breastfeeding. Do not give it to infants. It may contribute to a dangerous buildup of bilirubin in an infant, which can cause brain damage. The French agency ANSES also advises children, adolescents, and people with diabetes, liver disease, or heart disease to avoid berberine supplements. Severe heart rhythm disturbances with QT interval prolongation on ECG have been reported after berberine use. In one case, the person also took high doses of an oil containing cannabinoids. In another, an older man taking 500 mg of berberine daily developed an arrhythmia. Case reports cannot establish how often this happens, but fainting or pronounced palpitations require urgent medical evaluation. In the six-month BRAVO trial, serious adverse events were recorded in 6 of 169 participants on berberine and 2 of 168 on placebo. The difference was not statistically significant. Recording these events does not establish that berberine caused them. People who could not tolerate dosing during the run-in period were excluded before the main phase of the study.

In the News: Berberine ↗ · ANSES Opinion on the safety of use of berberine-containing plants in the composition of food supplements — Request 2018-SA-0095 ↗ · Harmless herbs? A case report of acquired long QT syndrome and torsades de pointes in a patient taking herbal supplements ↗ · Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report ↗ · Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗

Interactions

WithEffectActionSource
MidazolamIn 17 healthy men, overall exposure to midazolam increased by about 40% after two weeks of berberine at 300 mg three times daily. Berberine slowed the activity of enzymes involved in drug metabolism.Tell your doctor that you take berberine before midazolam is prescribed. Taking the two together requires a review.Repeated administration of berberine inhibits cytochromes P450 in humans ↗
CyclosporineIn kidney transplant recipients, berberine increased blood levels of cyclosporine. This medication requires careful dose management and blood level monitoring.Check with your treating doctor before adding berberine to cyclosporine. Your doctor should review the combination.Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study ↗
Other medicationsBerberine can alter how medications work. ANSES warns of numerous interactions, including with blood sugar-lowering drugs and some cancer drugs.Before starting berberine, review your full list of medications and supplements with a doctor or pharmacist.ANSES Opinion on the safety of use of berberine-containing plants in the composition of food supplements — Request 2018-SA-0095 ↗

Food sources

The berries of common barberry (Berberis vulgaris) are used in food. The amount of berberine in a serving depends on the berries used and how they are processed. A serving of berries or a dish made with them is not equivalent to a tablet dose. Ornamental barberry species are excluded from this list of foods.

Food composition

FoodGroupAmountServingCaloriesSources
Fresh common barberry berriesRipe Berberis vulgaris fruitBerries and products made from them—The composition study used Berberis vulgaris fruit. Researchers froze and dried freshly harvested samples before analysis. The berries differ in composition from the roots and bark.——The analysis of berberine content in the fruits of various species of barberry (Berberis sp.) by high performance thin-layer chromatography (HPTLC) ↗
Dried barberriesDried fruitBerries and products made from them—Dried barberries are used in cooking. The composition study also analyzed a commercially purchased dried sample.——The analysis of berberine content in the fruits of various species of barberry (Berberis sp.) by high performance thin-layer chromatography (HPTLC) ↗
Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts ↗
Barberries in rice dishesBerries added to a prepared dishBerries and products made from them—The berries are added to rice dishes as a seasoning.——Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts ↗
Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq ↗
Barberry juiceBerry drinkBerries and products made from them—The juice is made from the berries. Its composition depends on how it is prepared.——Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts ↗
Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq ↗
Barberry jam and barberry fruit jellyProcessed berriesBerries and products made from them—The berries are used to make jam and fruit jelly.——Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts ↗
Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq ↗
Barberry saucesProcessed berries used in a condimentBerries and products made from them—Barberries are used to make sauces.——Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq ↗

The analysis of berberine content in the fruits of various species of barberry (Berberis sp.) by high performance thin-layer chromatography (HPTLC) ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗Change in body weight Fat around the internal organs LDL cholesterolThe trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial.Berberine hydrochloride, 100 mg tablets. Participants took 500 mg twice daily after breakfast and dinner, for a total of 1 g/day, for six months. The comparator was matching placebo tablets. Both groups received diet and physical activity advice.Change in body weight — Over six months, body weight fell by an average of 1.8 kg with berberine and 1.9 kg with placebo. The trial found no additional weight loss with berberine. The adjusted difference was +0.05 kg, with a 95% confidence interval from −0.74 to +0.84 kg. Fat around the internal organs — The area of fat around the internal organs, measured by CT, fell by an average of 0.6% with berberine and 2.0% with placebo. The trial found no advantage for berberine. The adjusted difference in change was +1.38 percentage points, with a 97.5% confidence interval from −2.43 to +5.18. LDL cholesterol — Over six months, LDL cholesterol, often called “bad” cholesterol, fell by 7.72 mg/dL more with berberine than with placebo. The 95% confidence interval for the additional reduction was 1.93 to 13.13 mg/dL. This comparison did not assess how often heart attacks occurred.
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗Fasting blood sugarAdults aged 18–70 with newly identified elevated blood sugar. A total of 150 people were assigned to the two groups relevant to this comparison. The analysis included 49 in the berberine group and 99 in the control group.Berberine tablets. The article did not specify the chemical salt form. Participants took 500 mg twice daily, for a total of 1 g/day, for 16 weeks. The comparator was starch placebo tablets. Both groups also received placebo capsules in place of bifidobacteria.Fasting blood sugar — Over 16 weeks, average fasting blood sugar went from 6.49 to 6.20 mmol/L with berberine and from 6.43 to 6.67 mmol/L in the control group. The adjusted reduction relative to control was 0.50 mmol/L, with a 95% confidence interval from 0.15 to 0.85 mmol/L.

Sources

Sources
  1. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
  2. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗
  3. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗
  4. Dietary berberine supplementation improves select physiological and psychological responses during exertional heat stress: A pilot study in young adults ↗
  5. In the News: Berberine ↗
  6. Repeated administration of berberine inhibits cytochromes P450 in humans ↗
  7. The analysis of berberine content in the fruits of various species of barberry (Berberis sp.) by high performance thin-layer chromatography (HPTLC) ↗
  8. Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts ↗
  9. Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq ↗
  10. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study ↗
  11. Harmless herbs? A case report of acquired long QT syndrome and torsades de pointes in a patient taking herbal supplements ↗
  12. Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report ↗
  13. ANSES Opinion on the safety of use of berberine-containing plants in the composition of food supplements — Request 2018-SA-0095 ↗